1.Qiu Changlin's Treatment Experience of Treating Multiple Sclerosis Remission Stage with Nourishing Kidney and Extinguishing Wind
Hui QIU ; Liping ZHANG ; Changlin QIU
Journal of Zhejiang Chinese Medical University 2016;40(2):90-95
Objective] To sum up Qiu Changlin's clinical experience and academic views of treatment of multiple sclerosis remission stage. [Methods] Through the way of reviewing the related literature of traditional Chinese medicine, clinical practice with teacher, arranging medical records, systematically arranging Qiu Changlin's clinical experience and academic perspective in the aspects of etiology and pathogenesis, syndrome differentiation ,treatment ideas, drug integration of TCM and western medicine. [Results] Qiu Changlin believes that the MS remission stage is of deficiency syndrome or deficiency complicated with excess syndrome. The main pathogenesis is insufficiency of kidney yin and kidney yang, deficiency of governor vessel. The subject is wind and phlegm attacking into collateral, stagnation of phlegm and blood stasis. Put forward that the treatment based on the differentiation between the main syndrome and minor syndrome. In clinic, divided the main syndrome into three types, like insufficiency of kidney yin, insufficiency of kidney yang, insufficiency of kidney essence. Establish the therapeutic principles like nourishing yin and kidney, warming yang and nourishing kidney, the complementing of yin and yang, dispelling wind and dredging collaterals. The kidney yin deficiency type can modify Six Ingredient Rehmannia pill, Zhibaidihuang pill, Zuogui pill, Dabuyin pill, Huqian pill. The kidney yang deficiency type can modify Jingui Shenqi pill, Yougui pill. The kidney essence deficiency type can modify Dihuangyinzi. Regard that nourishing kidney and governing vessel to the fundamental treatment, ants going into collaterals to dispel the blood stasis and wind for treatment of the symptoms, and believe that nourishing kidney and extinguish wind should always run through the whole treatment process. When treatment based on the main syndrome, we should emphasize personalized features that can reflect the characteristics of this disease, in order to improve the clinical curative effect. [Conclusion] Qiu Changlin has rich clinical experience in the treatment of MS remission stage;patients are satisfactory to the curative effect and have fewer side effects. It's fully explained that TCM has certain advantages in the treatment of MS remission stage, and is worth popularizing inheritance.
2.High RNA accumulation in Candida tropicalis is affected by specific growth rate and different medium composition
Zhong LIN ; Zhongqiu LUO ; Jie DOU ; Hui WANG ; Weiran QIU ; Jing CAO ; Changlin ZHOU
Journal of China Pharmaceutical University 2011;42(2):169-175
Batch and continuous fermentation were adopted to investigate the effect of specific growth rate and amino acid components on RNA accumulation in Candida tropicalis ATCC 20408 in fermentation medium ( FM), yeast peptone dextrose medium (YPD), molasses fermentation medium ( MFM) and FM without corn steep liquor. The data showed that obvious differences in intracellular RNA accumulation were observed at different cell growth phases in bath fermentation prosess, and RNA level reached 11. 8% (g-RNA /g-DCW) during exponential phase, and only 6.9% during stationary phases. It was also found that intracellular RNA accumulation increased with the increase of specific growth rate in continue fermentation prosess, and the highest RNA level reached 15. 6% with the glucose conversion rate of 42. 8% at the dilution rate of 0. 5 h-1. Furthermore, the data showed that RNA lever was notably increased in batch fermentation process when amino acids or peptone was added into the fermentation medium containing no corn steep liquor. Taken together, it was reported for the first time that specific growth rate and amino acid components plays a leading role on the intracellular RNA accumulation in C. tropica lis, and specific growth rate is more important.
3.Short-term efficacy of sevelamer hydrochloride on hyperphosphatemia in patients undergoing maintenance hemodialysis
Yi FANG ; Xiaoqiang DING ; Jianzhou ZOU ; Yan FANG ; Jiaqi QIAN ; Shu RONG ; Changlin MEI ; Qiang QIU ; Xiangmei CHENG ; Zhihua ZHENG ; Xueqing. YU
Chinese Journal of Nephrology 2012;28(3):183-188
Objective To evaluate the short-term efficacy and safety of sevelamer hydrochloride in treating maintenance hemodialysis (MHD) patients with hyperphosphemia.Methods A multicenter,open-labeled,self-control study was performed.Phosphate binders were discontinued during a two-week washout period.Patients with more than 1.78 mmol/L serum phosphorus after two-week washout period were eligible for the trial.The dose was adjusted every two weeks as necessary to achieve serum phosphorus control. Sevelamer hydrochloride was administered to 138 MHD patients for 10 weeks and a second two-week washout period followed.Results A total of 111 from 138 patients fulfilled the whole 14-week study. Mean serum phosphorus and calcium-phosphate products starte to decline after two-week sevelamer hydrochloride treatment. By the end of 10-week sevelamer hydrochloride treatment, mean serum level of phosphorus [(1.85±0.50) vs (2.57±0.54) mmol/L,P<0.01],calcium-phosphate product [(4.16± 1.72) vs (5.79 ± 1.50) mmol2/L2,P<0.01 ] and low density lipoprotein [(1.64±0.76) vs (2.31 ±0.87) mmol/L,P<0.01] were significantly decreased,while the adjusted serum level of calcium and serum intact parathyroid hormone kept steady.Both serum phosphorus and calcium-phosphrus product increased after the second washout period, but the levels were still lower as compared to pre-treatment [(2.26±0.71) vs (2.57±0.54) mmol/L; (5.12±1.63) vs (5.79±1.50) mmol2/L2,P<0.01].Of the 138 patients involved,214 episodes in 106 patients and 121 episodes in 89 patients were reported as adverse events and adverse drug reaction respectively. Gastrointestinal symptoms,of which most were mild or moderate,happened to 68.1% (94/138) patients. Conclusions Sevelamer hydrochloride can control serum phosphorus and reduce the levels of calcium-phosphorus product and cholesterol.Slight gastrointestinal symptoms like constipation are common during the treatment.
4.Research progress on the relationship between Wnt/β-catenin signaling pathway and neurological disorders
Kangjie HONG ; Zhengxiang ZHANG ; Jingya LI ; Xuhong JIANG ; Changlin QIU ; Qun HOU ; Hui QIU
Journal of Chinese Physician 2020;22(5):789-793
Abundant clinical and basic studies in recent years reported the high association of Wnt/β-catenin signaling pathway with the incidence and development of multiple neurological disorders. In order to improve the attention about the relationship between Wnt/β-catenin signaling pathway and neurological disorders, and to provide new therapy target, this article reviews the research progress on the relationship between wnt/β-catenin signaling pathway and Parkinson′s disease, Alzheimer′s disease, epilepsy, multiple sclerosis and myasthenia gravis.
5.Correlations Between Single Nucleotide Polymorphisms, Cognitive Dysfunction, and Postmortem Brain Pathology in Alzheimer's Disease Among Han Chinese.
Qian YANG ; Kang CHEN ; Hanlin ZHANG ; Wanying ZHANG ; Changlin GONG ; Qing ZHANG ; Pan LIU ; Tianyi SUN ; Yuanyuan XU ; Xiaojing QIAN ; Wenying QIU ; Chao MA
Neuroscience Bulletin 2019;35(2):193-204
In this study, the distribution of five Alzheimer's disease (AD)-related single nucleotide polymorphisms (SNPs) in the Han population was examined in combination with the evaluation of clinical cognition and brain pathological analysis. The associations among SNPs, clinical daily cognitive states, and postmortem neuropathological changes were analyzed in 110 human brains from the Chinese Academy of Medical Sciences/Peking Union Medical College (CAMS/PUMC) Human Brain Bank. APOE ε4 (OR = 4.482, P = 0.004), the RS2305421 GG genotype (adjusted OR = 4.397, P = 0.015), and the RS10498633 GT genotype (adjusted OR = 2.375, P = 0.028) were associated with a higher score on the ABC (Aβ plaque score, Braak NFT stage, and CERAD neuritic plaque score) dementia scale. These results advance our understanding of the pathogenesis of AD, the relationship between pathological diagnosis and clinical diagnosis, and the SNPs in the Han population for future research.
ADAM10 Protein
;
genetics
;
Adult
;
Aged
;
Aged, 80 and over
;
Alzheimer Disease
;
genetics
;
pathology
;
Amyloid Precursor Protein Secretases
;
genetics
;
Antiporters
;
genetics
;
Apolipoprotein E4
;
genetics
;
Asian Continental Ancestry Group
;
genetics
;
Brain
;
pathology
;
Cognitive Dysfunction
;
genetics
;
pathology
;
Female
;
Genetic Predisposition to Disease
;
Humans
;
Male
;
Membrane Proteins
;
genetics
;
Middle Aged
;
Polymorphism, Single Nucleotide
6.Standardized Operational Protocol for Human Brain Banking in China.
Wenying QIU ; Hanlin ZHANG ; Aimin BAO ; Keqing ZHU ; Yue HUANG ; Xiaoxin YAN ; Jing ZHANG ; Chunjiu ZHONG ; Yong SHEN ; Jiangning ZHOU ; Xiaoying ZHENG ; Liwei ZHANG ; Yousheng SHU ; Beisha TANG ; Zhenxin ZHANG ; Gang WANG ; Ren ZHOU ; Bing SUN ; Changlin GONG ; Shumin DUAN ; Chao MA
Neuroscience Bulletin 2019;35(2):270-276
Brain
;
pathology
;
China
;
Humans
;
Organ Preservation
;
standards
;
Tissue Banks
;
ethics
;
standards